C4 THERAPEUTICS INC
CCCCNASDAQ🏆 #2747 by market capUS Equity
$3.98▲ $0.12 (+2.95%)
Live1h▲ 1.3%
24h▲ 3.0%
7d▲ 10.1%
14d▲ 13.2%
30d▲ 1.8%
1y▲ 77.1%
🏦Market Cap
$441M
Small Cap
📈Revenue Growth (YoY)
-12.4%
Declining
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
11.5x
Elevated
Otter Score
42
Weak
📊
Analyst Ratings
Price
$3.98
Total
14
Raised
1
Lowered
0
Avg PT
$7.00
H / L
$7 / $7
| Institution | Action | Rating | Date |
|---|---|---|---|
Evercore ISI Group | Reiterated | Outperform | 2026-06-01 |
Barclays | Reiterated | Overweight | 2026-02-27 |
Brookline Capital | Reiterated | Buy | 2026-02-23 |
Wells Fargo | Reiterated | Overweight | 2025-09-23 |
Stephens & Co. | Reiterated | Overweight | 2025-09-22 |
BMO Capital | Reiterated | Outperform | 2024-08-06 |
Stifel | Reiterated | Buy | 2024-05-09 |
Morgan Stanley | Reiterated | Equal Weight | 2024-02-26 |
JP Morgan | Upgraded | Underweight → Neutral | 2024-01-29 |
HC Wainwright & Co. | Reiterated | Buy | 2023-11-02 |
B of A Securities | Reiterated | Neutral | 2023-10-09 |
Credit Suisse | Reiterated | Underperform | 2022-04-28 |
UBS | Reiterated | Buy | 2022-04-18 |
SVB Leerink | Reiterated | Outperform | 2021-10-14 |
One row per institution, most recent rating